PT2385 is an orally active, small molecule inhibitor of hypoxia inducible factor (HIF)-2alpha, with potential antineoplastic activity. Upon oral administration, HIF-2alpha inhibitor PT2385 allosterically binds to HIF-2alpha, thereby preventing HIF-2alpha heterodimerization and its subsequent binding to DNA. This results in decreased transcription and expression of HIF-2alpha downstream target genes, many of which regulate tumor cell growth and survival.
Tags: buy PT-2385 | purchase PT-2385 | PT-2385 cost | order PT-2385 | PT-2385 chemical structure | PT-2385 in vivo | PT-2385 in vitro | PT-2385 formula | PT-2385 molecular weight